Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension of phase 3 duloxetine trial in chronic low back pain
jRCT2080222263Phase 3
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of duloxetine in chronic low back pain (CLBP) (2 arms), sponsored by Shionogi & Co., Ltd.
02
Drugs
duloxetine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on jRCT2080222263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222263.